The Effect of Maternal Peripartum Anti-TNFα Use on Infant Immune Response

This publication has 22 references indexed in Scilit:

• 540 Adalimumab and Infliximab Levels in Neonates (ERA Study)
  Gastroenterology, 2015
• Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease
  American Journal of Gastroenterology, 2013
• Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
  Clinical Gastroenterology and Hepatology, 2013
• 865 PIANO: A 1000 Patient Prospective Registry of Pregnancy Outcomes in Women With IBD Exposed to Immunomodulators and Biologic Therapy
  Gastroenterology, 2012
• The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics
  American Journal of Gastroenterology, 2011
• Relapses of Inflammatory Bowel Disease During Pregnancy: In-Hospital Management and Birth Outcomes
  American Journal of Gastroenterology, 2008
• Disease Activity in Pregnant Women With Crohn's Disease and Birth Outcomes: A Regional Danish Cohort Study
  American Journal of Gastroenterology, 2007
• Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid Arthritis
  American Journal of Gastroenterology, 2004
• Perinatal outcomes in inflammatory bowel disease
  The Journal of Maternal-Fetal & Neonatal Medicine, 2004
• Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response.
  Journal of Experimental Medicine, 1996